Search
Search Results
-
Applicability of obesity clinical practice guidelines in low- and middle-income countries
1289PDF: 638Appendix: 242HTML: 25 -
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3591PDF: 573Appendix: 410HTML: 28 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
1660PDF: 2676Supplementary: 335Appendix: 273 -
Lipoprotein(a): what clinicians need to know
448PDF: 809HTML: 27 -
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025
12668PDF: 8101Appendix: 1065 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
2021PDF: 534SUPPLEMENTARY MATERIAL: 304GRAPHICAL ABSTRACT: 269HTML: 34 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2411PDF: 410Appendix B: 443Appendix A: 326HTML: 2 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
215PDF: 248Supplementary: 154HTML: 25 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
827PDF: 233Supplementary: 150Appendix: 114HTML: 55 -
Dyslipidemia and stroke-related mortality in the United States: a nationwide analysis for 2010-2020
224PDF: 50Supplementary: 13HTML: 10 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
832PDF: 211Supplementary: 155Appendix: 109HTML: 40 -
Evolving targets for heart failure: the journey so far
2098pdf: 356HTML: 4 -
-
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1178PDF: 282Supplementary: 164HTML: 122 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2629PDF: 676Conflict of interest: 325SUPPLEMENTARY MATERIAL: 267HTML: 68 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1198pdf: 267Supplementary Material: 43HTML: 141 -
Modulation of cardiac metabolism in heart failure
2395PDF: 1171HTML: 32

